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Mushrooms are low calorie food with very little fat and are highly suitable for obese persons.
With no starch and very low sugars, they are the ‘delight of the diabetics’. Combination of
herbal drugs (or isolated phytochemicals) is found to be beneficial in certain diseases when
given along with conventional drugs. The aim of the present study was to evaluate the effects of
aqueous extract of Pleurotus pulmonarius (Lentinaceae) (called as PP-aqu) and its interaction
with glyburide in alloxan induced diabetic mice. The diabetic mice treated were with PP-aqu
(500mg/kg, p.o.) alone or combination with glyburide (10mg/kg, p.o.) for 28 days. Blood
samples were collected by orbital sinus puncture using heparinized capillary glass tubes and
were analyzed for serum glucose on 0, 7th, 14th, 21st and 28th days. Body weights and
mortality were noted during the study period. In oral glucose tolerance test (OGTT), glucose
(2.5g/kg, p.o.) was administered with either vehicle, PP-aqu alone or in combination with
glyburide and serum glucose level analyzed at 0, 30, 60 and 120min after drug administration.
Administration of PP-aqu (500mg/kg) and its combination with glyburide (10mg/kg)
significantly (P50.001) decreased serum glucose level in diabetic mice. In OGTT, glyburide
or PP-aqu treatment alone or their combination produced significant (P50.001) increase in
glucose threshold. Thus we suggest that P. pulmonarius showed potent and synergistic
antihyperglycemic effect in combination with glyburide.
Keywords: Pleurotus pulmonarius–glyburide–serum glucose–oral glucose
tolerance test (OGTT)
Introduction
Mushrooms are a group of fleshy macroscopic fungi,
which until recently, as other fungi, were induced in the
plant kingdom because of cell wall and spores.
Mushroom have been valued throughout the world as
both food and medicine for thousands of years (1–3).
There are many varieties of mushrooms, species of
which Pleurotus are characterized by a white spore
print, attached to gills, often with an eccentric stip,
or no stip at all. They are commonly known as ‘oyster
mushrooms’ (4).
Mushrooms are highly nutritive as they contain good
quality proteins, vitamins and minerals (5,6). Mushrooms
are low calorie food with very little fat and are highly
suitable for obese persons. With no starch and very low
sugars, they are the ‘delight of the diabetics’ (7). In
adequate quantities and low in sugars they can serve as
medicinal foods for diabetes. Earlier studies have
reported insulin release and insulin like activity of other
mushroom species like Agaricus campestris (8–10).
However, there is paucity of reports on the antihyper-
glycemic activity of Pleurotus.
The increasing use of herbal medicinal products in the
community where people are also receiving prescription
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properly cited.medicines suggests that adverse herb-drug interactions
may be of significant public health consequence (11).
Geriatric patients often add herbal medicines to medica-
tions prescribed by their physicians, yet do not always
inform the physician (12). Whereas most herbal remedies,
when used as directed and under the supervision of
knowledgeable individuals, are safe, the potential for
adverse effects or intoxications certainly exists. In
addition, because nearly all herbal remedies contain
multiple, biologically active constituents, interaction
with conventional drugs is a concern (13–15). Hence,
the likelihood of herb–drug interactions is theoretically
higher than drug–drug interactions (16). On the other
hand, combination of herbal drugs (or isolated phyto-
chemicals) are found to be beneficial in certain diseases
(17–19) when given along with conventional drugs.
Herbal agents when given in combination with prescrip-
tion medication may favorably alter pharmacokinetic (20)
as well as pharmacodynamic (19,21,22) of prescription
medications. However, to date there is less evidence
relating to herb–drug interaction in case of antidiabetic
medicines and understanding of the involved mechanisms
is also far from complete (16).
Recently, we have reported the hypoglycemic effects
of aqueous extract of Pleurotus pulmonarius (Fr.)
Quel.-Champ in alloxan-induced diabetic mice and
increased oral glucose tolerance in diabetic (OGTT
model) mice at dose levels  250mg/kg, p.o. (23). In
this article we are reporting interaction of aqueous
extract of P. pulmonarius with glyburide on serum
glucose levels and oral glucose tolerance test (OGTT) in
alloxan-induced diabetic mice.
Methods
Drugs and Chemicals
The mushroom of P. pulmonarius (Fr.) Quel.-Champ
(Lentinaceae) was provided to us as a gift sample from
Bajaj Orchard, Pvt. Ltd, Mumbai, India. It was
authenticated by Dr A. M. Mujumdar, Department of
Botany, at Agharkar Research Institute, Pune and
voucher specimen was deposited at that Institute.
Glyburide (Ranbaxy Pharma. Ltd, India), alloxan mono-
hydrate (Spectrochem, India), glucose estimation kit
(Accurex Biomedical Pvt. Ltd, India) and d-glucose
(S.D. Fine-Chem. Ltd, India) were purchased from
respective companies.
Experimental Animals
Swiss albino male mice (25–30g) were purchased from
National Toxicology Centre, Pune, India. They were
maintained at a temperature of 25 1 C and relative
humidity of 45–55% under 12-h light:12-h dark cycle.
The animals had free access to food pellets (Chakan Oil
Mills, Pune, India) and water ad libitum. The experi-
mental protocol was approved by the Institutional
Animal Ethics Committee (IAEC) of Poona College of
Pharmacy, Pune, India.
Preparation of Aqueous Extract of P. pulmonarius
(PP-aqu)
Weighed quantity powder of air-dried P. pulmonarius
was added to distilled water (1:15), boiled for 20min on
water bath, cooled to room temperature and filtered. The
filtrate was dried on tray dryer at 70 C (yield 24% w/w).
The dry extract powder was dissolved in distilled water to
prepare drug solution at a concentration of 100mg/ml
and used for pharmacological studies.
Induction of Experimental Diabetes
Diabetes was induced in mice by a single intravenous
injection of aqueous alloxan monohydrate (70mg/kg, i.v.)
(24). After 48h, the animals showing serum glucose level
above 200mg/dl (diabetic) were selected for the study.
All mice were allowed free access to tap water and pellet
diet.
Collection of Blood and Determination of Serum Glucose
Blood samples from the control and experimental mice
were collected by orbital sinus puncture using heparinized
capillary glass tubes. The blood samples so collected were
analyzed for glucose levels by glucose oxidase peroxidase
(GOD/POD) method as described earlier (25) and serum
glucose levels were expressed in mg/dl.
Alloxan Treated Diabetic Mice Model
The diabetic mice were divided into four groups of six
animals each. The mice were administered orally with
either vehicle (distilled water, 10ml/kg), PP-aqu
(500mg/kg), glyburide (10mg/kg) and the combination
of PP-aqu (500mg/kg) with glyburide (10mg/kg).
Acute study involved estimation of serum glucose at 0,
2, 4, 6 and 24h after drug administration. Subacute study
involved repeated administration of drug for 28 days at
prefixed time and serum glucose level was estimated on
7th, 14th, 21st and 28th day. Mean change in serum
glucose level and standard error mean (SEM) were
calculated. The mice were weighed daily during the
study period of 28 days and their body weights were
noted. From this data, mean change in body weight and
SEM were calculated. The mortality of mice was also
noted during the study period and percentage mortality
was calculated.
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Diabetic Mice
Diabetic mice were divided into four groups of six
animals each. The animals were fasted overnight before
commencing the experiment.They were adminstred orally
with either vehicle (distilled water, 10ml/kg), PP-aqu
(500mg/kg), glyburide (10mg/kg) and the combination of
PP-aqu (500mg/kg) with glyburide (10mg/kg). The mice
of all the groups were loaded with d-glucose (2.5gm/kg)
solution after half an hour of drug administration. Serum
glucose levels were estimated 30min prior to glucose
administration and at 0, 30, 60 and 120min after glucose
loading.
Statistical Analysis
The results are expressed as mean   SEM. Comparison
between the groups was made by two-way analysis of
variance (ANOVA) followed by post hoc Dunnett’s test.
Results
Antihyperglycemic Influence on Serum Glucose Level
in Alloxan-induced Diabetes
Figure 1 showed antihyperglycemic effects of various
treatments against alloxan-induced diabetic mice. Acute
administration of PP-aqu (500mg/kg) showed peak
decrease in serum glucose levels in alloxan-induced
diabetic mice at 2h (P50.001). However, effects gradu-
ally reduced at 4h (P50.01) and 6h (P50.01). Glyburide
(10mg/kg) showed potent and significant effect
(P50.001) at all time points tested. However, combina-
tion of PP-aqu (500mg/kg) and glyburide (10mg/kg)
demonstrated sharp decrease (P50.001) in serum glucose
levels at all the time points tested (Fig. 1).
Sub-acute Antihyperglycemia on Serum Glucose
Levels in Alloxan Induced Diabetes
Glyburide (10mg/kg), PP-aqu (500mg/kg) or their
combinations showed significant (P50.001) antihyper-
glycemic effect after 7th, 14th, 21st and 28th day of
treatments. The effects of combinations were more
pronounced than single drug treatment (Fig. 2).
Reversal of Loss of Body Weight and Mortality
Rate in Alloxan Induced Diabetes
Administration of vehicle (distilled water, 10ml/kg, p.o.)
in alloxan induced diabetic mice resulted in gradual
decease (P50.001) in body weight during the period of
28 days (Fig. 3). All the treatments (PP-aqu or glyburide
or their combinations) could reverse alloxan-induced
weight loss in mice after 7th, 14th, 21st and 28th day
of treatments (Fig. 3). Administration of PP-aqu alone
caused 14% mortality in alloxan induced diabetic mice
during 28 days study period (Data not tabulated). On
single drug treatment of glyburide (10mg/kg) caused
25% mortality, whereas combination of PP-aqu with
glyburide (10mg/kg) caused 25% mortality in mice.
Increased Glucose Threshold in OGTT by Treatments
In the OGTT, administration of glucose load (2.5g/kg)
increased serum glucose levels significantly (P50.001)
after 30min of glucose loading in alloxan treated diabetic
mice (Fig. 4). Glyburide (10mg/kg) or PP-aqu treatment
alone or in combination produced significant (P50.001)
increase in glucose threshold within 30min of glucose
Figure 1. Effect of acute pretreatment of aqueous extract of
P. pulmonarius and glyburide on serum glucose level in alloxan-induced
diabetes in mice.
Figure 2. Effect of subacute pretreatment of aqueous extract of
P. pulmonarius and glyburide on serum glucose level in alloxan induced
diabetes in mice.
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Table 1).
Discussion
In the past, many mushroom varieties have been reported
to possess hypoglycemic activities in animals (8,10) as
well as in diabetic patients (26). Studies in normal and
streptozotocin diabetic mice treated with mushroom
variety, Agaricus bisporus, retards the development of
hyperglycemia, hyperphagia, polydipsia, body weight loss
and glycated hemoglobin in streptozotocin treated mice
(10) by counteracting reduction in plasma and pancreatic
insulin concentration and by improving hypoglycemic
effect of exogenous insulin.
The antihyperglycemic effect of PP-aqu was limited to
6h (with peak effect at second h) when administered
alone. But combination of PP-aqu and gliburide showed
sustained anti-hyperglycemic effect at 24h (Fig. 1)
suggesting the advantage of combination in long-term
treatment. The more pronounced effect of the extract in
alloxan-induced diabetic mice may possibly be due to
limited or compromised action of insulin in diabetic
condition, and conversely a greater and more direct
role of the antihyperglycemic principle present in the
extract. Several antihyperglycemic principles from
plant origin have been reported to have antihypergly-
cemic effects upto 24h (27–29). On the other hand,
combination of PP-aqu with glyburide showed its
peak effect at 24h. It thus seems possible that
more than one phytochemical from PP-aqu showed
antihyperglycemic effect.
Moreover, PP-aqu alone or in combination with
glyburide also protected the weight loss induced by
alloxan in the present study (Fig. 3) and this result is
supported by earlier studies from few other plant extracts
(10) and so substantiates the usefulness of combination in
long-term treatment of diabetes.
In OGTT, the doses of PP-aqu (500mg/kg, p.o.)
increased the tolerance for glucose (Fig. 4) suggesting
increased peripheral utilization of glucose in both diabetic
as well as nondiabetic (normal) mice.
Antihyperglycemic effects observed in alloxan induced
mice and in OGTT can be attributed to several
mechanisms. Many varieties of mushrooms have been
reported to possess antihyperglycemic activity through
various mechanism like glucose/insulin metabolism
and/or by enhancing peripheral insulin sensitivity (9,30)
or by enhancing insulin release by Islets of Langerhans
(8,31). Insulin-releasing and insulin-like activity in A.
campestris (a variety of mushroom) is reported earlier (8).
Table 1. Effect of treatments on increased glucose threshold in OGTT
Treatment (dose in mg/kg, p.o.) Mean serum gluose level (mg/dl)
 30 Omin 30min 60min 120min
Vehicle 421.53 18.59 465.76 4.54 457.46 11.22 385.90 11.02 434.62 12.16
PP-aqu (500) 489.35 20.75 542.69 8.44 310.43 8.37*** 326.69 10.29*** 485.56 10.39*
Glybu (10) 474.80 20.85 514.38 6.47 333.05 5.13*** 339.13 9.56*** 472.68 7.28
PP-aqu (500)þGlybu (10) 501.44 12.78 468.95 1.25 288.81 15.90*** 294.37 15.81*** 278.35 18.22***
N¼6, PP-aqu- of aqueous extract of P. pulmonarius; Glybu-Glyburide. All the groups were administrated with glucose load (2.5g/kg) at 0min.
*P50.05, ***P50.001.
Figure 3. Effect of sub-acute pretreatment of aqueous extract of
P. pulmonarius and glyburide on body weights of alloxan induced
diabetes in mice.
Figure 4. Effect of acute pretreatment of aqueous extract of
P. pulmonarius and glyburide on serum glucose level in OGTT in mice.
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insulin and glucagon release from isolated rat islets in the
presence of glucose and specific interaction between
mushroom lectin and its receptors (leading to conforma-
tional changes in the structure of the membranes of the
islet a2- and b-cells) that facilitate exocytosis is also
proposed earlier (31). Effects of water-soluble extract of
maitake mushroom have been reported to have anti-
hyperglycemic activity by lowering of circulating glucose
and insulin concentrations and suggested to work
primarily by enhancing peripheral insulin sensitivity
(32). Therefore, P. pulmonarius mediated decrease in
serum glucose level in diabetic mice may mediated by one
of these mechanisms.
Guanide, a known hypoglycemic substance related to
biguanide class of oral antidiabetic drugs, has been
detected in edible mushroom of Pleurotus species (33) and
might be responsible for the antidiabetic effect. This
phytochemical may be responsible for synergistic action
of PP-aqu with glyburide against alloxan-induced dia-
betic mice as well as OGTT that is observed in our study.
It is generally agreed that glyburide binds to insulin
receptors on beta cells. Following this binding, closure
of ATP-dependent potassium channels leads to opening
of voltage-gated Ca
2þ channels, an increased Ca2þ influx
and the subsequent stimulation of insulin containing
granules’ exocytosis. (34–37) and reduces fasting plasma
glucose concentration.
Mushrooms contain a variety of secondary metabolites,
including various phenolic compounds, which have been
may act as excellent anti-oxidants (38–42). Oxidative
stress, defined as an imbalance between the production of
reactive oxygen species (ROS) and anti-oxidant defense,
is considered to be an important pathogenic factor in
diabetes mellitus and its complications (43). It has been
postulated that enhanced generation of ROS may
take part in the pathogenesis of diabetic microvascular
complication—retinopathy (44). The relationship of
anti-oxidant potential of herbs and their antidiabetic
activity have been shown many times in the past (45–50).
Niacin-bound chromium constituent from Maitake
mushroom (9,51) and nicotinamide (52) is reported to
ameliorate diabetes mellitus in laboratory animals as well
as in clinics. Therefore, anti-oxidant components in
PP-aqu (niacin and ascorbic acid that are present
in remarkable proportion) might play important
contributory factor in the antihyperglycemic effect of
P. pulmonarius.
Preliminary phytochemical analysis of P. pulmonarius
showed the presence of proteins, minerals, vitamins and
carbohydrates (Data not tabulated). Such constituents
are confirmed also by Food and Agriculture Organiza-
tion of United Nations (53). Mushrooms consist of
 20–35% proteins. The glycoproteins constituents
have been shown to have antihypergycemic effect (54).
Conclusions
It was thus apparent from the results that PP-aqu
(500mg/kg) showed significant antihyperglycemic effect
in alloxan induced diabetic mice. It not only halts
progression of diabetes (as it reduced weight loss) but
also reduced the mortality of alloxan induced diabetic
mice by  50%. PP-aqu (500mg/kg) in combination with
glyburide (10mg/kg) showed potent synergistic antihy-
perglycemic effects probably due to increased insulin
secretion. The results from OGTT also supports the
possibility of effective combination therapy of
P. pulmonarius with glyburide as an effective anti-diabetic
therapy. The marked and prolonged activity necessitates
a more comprehensive chemical and pharmacological
investigation to elucidate the exact mechanism and to
isolate and identify it’s active principle(s).
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